Exscientia stock.
In light of these risks and uncertainties, and other risks and uncertainties that are described in the Risk Factors section and other sections of Exscientia’s Annual Report on Form 20-F, filed with the Securities and Exchange Commission (SEC) on March 23, 2022 (File No. 001-40850), and other filings that Exscientia makes with the SEC from ...
7 months ago - Business Wire. Get a real-time Exscientia plc (EXAI) stock price quote with breaking news, financials, statistics, charts and more.Jan 20, 2023 · Of course Exscientia may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying. View Exscientia PLC Sponsored ADR EXAI investment & stock information. Get the latest Exscientia PLC Sponsored ADR EXAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Overview | EXAI U.S.: Nasdaq Exscientia PLC ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 30, 2023 5:47 a.m. EST Delayed quote $ 6.01 0.01 0.17% Before Hours Volume: 87... It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...
Revenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ...Find the latest Hon Hai Precision Industry Co., Ltd. (HNHPF) stock quote, history, news and other vital information to help you with your stock trading and investing.On average, Wall Street analysts predict. that Exscientia's share price could reach $10.00 by Oct 17, 2024. The average Exscientia stock price prediction forecasts a potential upside of 63.13% from the current EXAI share price of $6.13.
On average, Wall Street analysts predict. that Exscientia's share price could reach $10.00 by Oct 17, 2024. The average Exscientia stock price prediction forecasts a potential upside of 63.13% from the current EXAI share price of $6.13.
Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 5.38% so far this month. During the month of March, Exscientia PLC (ADR)’s stock price has reached a high of $7.11 and a low of $6.02. Over the last year, Exscientia PLC (ADR) has hit prices as high as $17.66 and as low as $4.09. Year to date, Exscientia ...Exscientia is an artificial intelligence-driven pharmatech company that discovers, designs, and develops drugs. The company's stock price, news, and …Another stock in the Medical sector, Exscientia PLC Sponsored ADR (EXAI), has outperformed the sector so far this year. The stock's year-to-date return is 9.6%.31 июл. 2022 г. ... Conclusion. Exscientia is at the vanguard of the AI drug discovery revolution. It is working with some impressive pharma companies on some ...Dec 1, 2023 · Exscientia PLC Sponsored ADR (EXAI) Stock Jumps 13.5%: Will It Continue to Soar? finance.yahoo.com - October 12 at 9:54 AM: Exscientia plc (NASDAQ:EXAI) most popular amongst individual investors who own 58% of the shares, institutions hold 27% finance.yahoo.com - October 11 at 8:42 AM
Recent advancements in the Company’s pipeline, collaborations and operations as well as financial results for the fourth quarter and full year 2021 are summarised below. In addition, Exscientia will host a conference call on Thursday, March 24 at 12:30 p.m. GMT / 8:30 a.m. ET to provide an overview of the company's end-to-end technology ...
TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.A company might ordinarily make 2,500 to 5,000 compounds over five years when developing a new drug. Exscientia made 136 for one of its new cancer drugs, in just one year. ...Dec 1, 2023 · The Exscientia plc stock price gained 1.15% on the last trading day (Friday, 1st Dec 2023), rising from $6.10 to $6.17. During the last trading day the stock fluctuated 5.73% from a day low at $5.93 to a day high of $6.27. The price has been going up and down for this period, and there has been a 3.35% gain for the last 2 weeks. Exscientia presents Q3 figures on November 9. Analysts predict Exscientia will report losses per share of $0.404. Track Exscientia stock price in real-time on Markets Insider here. Exscientia ...OXFORD, U.K., September 20, 2023--Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Merck KGaA, Darmstadt, Germany focused on the discovery of novel small molecule drug ...One reason for this week's share growth was the company's first-quarter earnings report. Its reported revenue of $7.1 million was down 17.4% year over year, and its net loss was $46.6 million, 143 ...
According to 3 stock analysts, the average 12-month stock price forecast for Exscientia stock is $10, which predicts an increase of 62.07%. The lowest target is $7.00 and the highest is $13. On average, analysts rate Exscientia stock as a buy.2012. 481. Andrew Hopkins. https://www.exscientia.ai. Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and ...How much is Exscientia stock worth today? ( NASDAQ: EXAI) Exscientia currently has 124,511,492 outstanding shares. With Exscientia stock trading at $6.17 per share, the total value of Exscientia stock (market capitalization) is $768.24M. Exscientia stock was originally listed at a price of $27.10 in Oct 1, 2021.Oct 11, 2023 · In the last 3 months, 7 analysts have offered 12-month price targets for Exscientia. The company has an average price target of $12.86 with a high of $14.00 and a low of $7.00. Below is a summary ... EXS73565. MALT1. * Phase 3 may not be required if Phase 2 is registrational: PKC-theta is in a Phase 1 healthy volunteer study. Does not include Sumitomo Pharma programmes. Our pipeline demonstrates our ability to rapidly translate scientific concepts and patient-centric data into precision-designed therapeutic candidates. Exscientia Stock Up 2.1 %. NASDAQ:EXAI opened at $5.40 on Wednesday. The firm’s 50 day simple moving average is $5.70 and its 200 day simple moving average is $6.18. The company has a debt-to ...PARIS, OXFORD, and BOSTON – January 7, 2022 – Sanofi and Exscientia announced today a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule ...
Nov 24, 2023 · Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 14.81% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.51 and a low of $4.95. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ... PR Contacts: Edelman PR: Anitra Sprauten P: +44 (0)78 9685 9386 [email protected] Stephanie Crisp P: +44 (0)75 8300 3417 [email protected] For Exscientia Mark Swindells, Chief ...
Oct 11, 2023 · In the last 3 months, 7 analysts have offered 12-month price targets for Exscientia. The company has an average price target of $12.86 with a high of $14.00 and a low of $7.00. Below is a summary ... Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets. The Company will host a ...Company profile page for Exscientia Plc including stock price, company news, press releases, executives, board members, and contact informationRevenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ...A. While ratings are subjective and will change, the latest Exscientia ( EXAI) rating was a maintained with a price target of $12.00 to $10.00. The current price Exscientia ( EXAI) is trading at ...Find the latest Schrödinger, Inc. (SDGR) stock quote, history, news and other vital information to help you with your stock trading and investing.4 окт. 2021 г. ... The Oxford, U.K.-based company offered more than 13.8 million American depositary shares priced at $22 apiece, which was the top end of the ...Find the latest Hon Hai Precision Industry Co., Ltd. (HNHPF) stock quote, history, news and other vital information to help you with your stock trading and investing.Apr 12, 2022 · This results in a target price of $34.4 (12.74 x 2.7) based on the current share price. This is a high target in view of current market conditions where stocks with negative earnings are being ... Oct 1, 2021 · Exscientia’s market value soared as shares of the artificial intelligence (AI) p harmaceutical-technology (pharmatech) company debuted on the stock market. Shares of the Oxford, England company rose more than 30% following Exscientia’s upsized initial public offering (IPO).
AbbVie Inc. Common Stock (ABBV) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 7.65% so far this month. During the month of June, Exscientia PLC (ADR)’s stock price has reached a high of $8.39 and a low of $6.70. Over the last year, Exscientia PLC (ADR) has hit prices as high as $16.45 and as low as $4.09. Year to date, Exscientia ...
Find the latest Exscientia plc (EXAI) stock quote, history, news and other vital information to help you with your stock trading and investing.Exscientia Plc (EXAI) Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Exscientia Plc today and set a price target of $14.00 . The company’s shares closed last Thursday at $5.04 ...Exscientia Announces Pricing of $304.7 Million Upsized Initial Public Offering and $160.0 Million Concurrent Private Placements. OXFORD, England-- ( BUSINESS …Jul 11, 2023 · The Schrödinger Building Oxford Science Park, Oxford OX4 4GE . Phone: +44 (0) 1865 818941 Cash inflows: For the full year 2022, Exscientia received $117.8 million in cash inflows from its collaborations as compared to $85.3 million during the full year 2021. Net Operating cash flow and cash balance: For the full year ending December 31, 2022, net operating cash outflows were $73.1 million, in comparison to net operating cash inflows ...Exscientia plc : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: EXAI | NasdaqIn parallel, Exscientia is building a new 26,000 square foot robotic laboratory at nearby Milton Park, Oxfordshire focused on the automation of chemistry and biology to accelerate drug discovery. This will take Exscientia towards its goal of drugs designed by AI, made by robot. “Exscientia has grown significantly in 2021, driven by new ...Successfully navigating the dynamic landscape of stock investing requires an understanding of factors like momentum to judge a stock’s price trend. In this article, we take an in-depth look at Exscientia PLC (ADR) (EXAI) to unravel why momentum evaluation plays a crucial role in making savvy investment choices.The consensus price target hints at a 76.1% upside potential for Exscientia PLC Sponsored ADR (EXAI). While empirical research shows that this sought-after metric is hardly …Dec 1, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Exscientia stock is $10, which predicts an increase of 62.07%. The lowest target is $7.00 and the highest is $13. On average, analysts rate Exscientia stock as a buy. OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced the expansion of its platform to include the design of biologics, such as human antibodies. The Company has progressed AI-driven capabilities for virtual biologics design throughout the year and is now establishing an automated biologics laboratory in …
Morgan Stanley Global Healthcare Conference 2023. Webcast. 09/07/2023 3:45 PM ET.Exscientia (NASDAQ:EXAI) has observed the following analyst ratings within the last quarter: These 4 analysts have an average price target of $14.0 versus the current price of Exscientia at $6.1 ...These 4 analysts have an average price target of $14.0 versus the current price of Exscientia at $6.1, implying upside. Below is a summary of how these 4 analysts rated Exscientia over the past 3 ...Find the latest Exscientia plc (EXAI) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. wp carey dividendbest material stocksdechra pharmaceuticalsvalue of copper in a penny MarketWatchOXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced data from its Phase 1 healthy volunteer study of EXS-21546, its highly selective A 2A receptor antagonist co-invented and developed through a collaboration between Exscientia and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, … israel stock marketsgov ex dividend date First AI platform clinically validated to improve treatment outcomes in prospective study. Exscientia, a clinical stage pharmatech company, has entered into a binding agreement to acquire Allcyte, a leader in artificial intelligence (AI) based precision medicine. The combination expands Exscientia’s translational capabilities by enabling …OXFORD, England-- (BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) will report financial results for the second quarter ended June 30, 2023, on Thursday August 10, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review … long call calculator PR Contacts: Edelman PR: Anitra Sprauten P: +44 (0)78 9685 9386 [email protected] Stephanie Crisp P: +44 (0)75 8300 3417 [email protected] For Exscientia Mark Swindells, Chief ...Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. GMT / 8:30 a.m. EST to provide a business update and review financial results.